Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.17−0.02 (-0.63%)
Close on Nov 18, 2026Market cap $1.17BP/E 15.8Yield –
Cronos operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cronos's operating income for the twelve months ending Jun 30, 2026 was -$2.43M. For fiscal 2025 it was -$17.40M. The highest annual figure on record is -$6.12M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.40M | – |
| FY2024 | Dec 31, 2024 | -$76.53M | – |
| FY2023 | Dec 31, 2023 | -$84.80M | – |
| FY2022 | Dec 31, 2022 | -$111.43M | – |
| FY2021 | Dec 31, 2021 | -$291.97M | – |
| FY2020 | Dec 31, 2020 | -$219.39M | – |
| FY2019 | Dec 31, 2019 | -$153.32M | – |
| FY2018 | Dec 31, 2018 | -$20.45M | – |
| FY2017 | Dec 31, 2017 | -$6.12M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.83M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$503.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.32M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$33.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.95M | – |
| Q4 FY2023 | Dec 31, 2023 | -$21.64M | – |
| Q3 FY2023 | Sep 30, 2023 | -$21.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$20.62M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.77M | – |
| Q4 FY2022 | Dec 31, 2022 | -$27.03M | -125.5% |
| Q3 FY2022 | Sep 30, 2022 | -$27.33M | – |
| Q2 FY2022 | Jun 30, 2022 | -$25.30M | – |
| Q1 FY2022 | Mar 31, 2022 | -$36.05M | – |
| Q4 FY2021 | Dec 31, 2021 | $105.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$56.41M | – |
| Q2 FY2021 | Jun 30, 2021 | -$296.35M | – |
| Q1 FY2021 | Mar 31, 2021 | -$45.20M | – |
| Q4 FY2020 | Dec 31, 2020 | -$58.45M | – |
| Q3 FY2020 | Sep 30, 2020 | -$41.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$74.71M | – |
| Q1 FY2020 | Mar 31, 2020 | -$45.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$95.78M | – |
| Q3 FY2019 | Sep 30, 2019 | -$30.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.76M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.13M | – |
See a number that looks wrong?